These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1785190)

  • 21. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
    de Boer SM; Kortekaas J; Antonis AF; Kant J; van Oploo JL; Rottier PJ; Moormann RJ; Bosch BJ
    Vaccine; 2010 Mar; 28(11):2330-9. PubMed ID: 20056185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
    Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
    Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping a Major Gene for Resistance to Rift Valley Fever Virus in Laboratory Rats.
    Busch CM; Callicott RJ; Peters CJ; Morrill JC; Womack JE
    J Hered; 2015; 106(6):728-33. PubMed ID: 26546799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New vectors of Rift Valley fever in West Africa.
    Fontenille D; Traore-Lamizana M; Diallo M; Thonnon J; Digoutte JP; Zeller HG
    Emerg Infect Dis; 1998; 4(2):289-93. PubMed ID: 9621201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental infection of cattle with pantropic Rift Valley fever virus.
    Coackley W; Pini A; Gosden D
    Res Vet Sci; 1967 Oct; 8(4):399-405. PubMed ID: 6064502
    [No Abstract]   [Full Text] [Related]  

  • 26. Animal models of Rift Valley fever virus infection.
    Ross TM; Bhardwaj N; Bissel SJ; Hartman AL; Smith DR
    Virus Res; 2012 Feb; 163(2):417-23. PubMed ID: 22086058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rift valley fever. A threat for Middle Europe?].
    Mussgay M
    Dtsch Med Wochenschr; 1980 Sep; 105(37):1265-6. PubMed ID: 7191369
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro activity of Russian ribavirin on the models of Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, and Tahyna and Dhori viruses].
    Belov AV; Larichev VF; Galkina IA; Khutoretskaia NV; Butenko AM; Konstantinova ID; Muzyka IS; Galegov GA
    Vopr Virusol; 2008; 53(1):34-5. PubMed ID: 18318134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
    Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
    Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus-like particle-based countermeasures against Rift Valley fever virus.
    Koukuntla R; Mandell RB; Flick R
    Zoonoses Public Health; 2012 Sep; 59 Suppl 2():142-50. PubMed ID: 22958258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.
    Garcia S; Crance JM; Billecocq A; Peinnequin A; Jouan A; Bouloy M; Garin D
    J Clin Microbiol; 2001 Dec; 39(12):4456-61. PubMed ID: 11724861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One Health approach to Rift Valley fever vaccine development.
    Kortekaas J
    Antiviral Res; 2014 Jun; 106():24-32. PubMed ID: 24681125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of immobilized liposomal preparations of ribamidil in experimental Rift Valley fever].
    Grabareva LP; Khamitov RA; Pshenichnov VA
    Vopr Virusol; 1991; 36(6):512-4. PubMed ID: 1785190
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of the peroxidation of ribamidil-containing liposomes on the results of chemotherapy in experimental viral infections].
    Khamitov RA; Grabareva LP; Pshenichnov VA; Eres'kina OA
    Vopr Virusol; 1993; 38(1):21-4. PubMed ID: 8073740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice.
    Kende M; Alving CR; Rill WL; Swartz GM; Canonico PG
    Antimicrob Agents Chemother; 1985 Jun; 27(6):903-7. PubMed ID: 4026264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The antiviral activity of inhibitors of ADP ribosylation in experimental alpha- and bunyavirus infections].
    Krasil'nikov II; Levshina EV; Belova RI; Starenchenko VV; Tsikarishvili GV; Katsalukha VV
    Vopr Virusol; 1994; 39(2):85-7. PubMed ID: 8017062
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.